Company Filing History:
Years Active: 2010-2015
Title: The Innovations of Jesper Haaning
Introduction
Jesper Haaning, an accomplished inventor based in Birkeroed, Denmark, is known for his significant contributions to the field of medical therapeutics, particularly in the treatment of blood clotting diseases. With an impressive portfolio of five patents, Haaning's work intertwines scientific research with innovative solutions in medicine.
Latest Patents
Among his notable inventions, Haaning has developed compounds suitable for the treatment of hemophilia. This invention pertains to Von Willebrand factor (VWF) compounds and compositions designed to address blood clotting disorders. His pharmaceutical formulations comprise a Factor VIII molecule and a VWF compound, showcasing his focus on improving patient care in hematology.
Another significant patent includes variants of human Factor VII or human Factor VIIa that involve modifications to the Gla domain. This innovation introduces amino acid modifications beneficial for treating intracerebral hemorrhage (ICH) or trauma, marking another major advancement in Haaning's body of work.
Career Highlights
Throughout his career, Jesper Haaning has held positions with prominent companies such as Bayer Healthcare LLC and Novo Nordisk A/S. His experience in these esteemed organizations has bolstered his reputation as a leading inventor in the pharmaceutical industry.
Collaborations
Haaning has also collaborated with various industry professionals, including Kim Vilbour Andersen and Claus Bornaes. These partnerships have enabled him to blend expertise and knowledge, further enhancing the development and application of his innovative approaches.
Conclusion
In summary, Jesper Haaning's inventive spirit and dedication to improving medical treatments through his patents have established him as a noteworthy figure in the realm of healthcare innovations. His contributions in the field of blood clotting diseases exemplify the impactful role of inventors in advancing medical science and improving patient lives.